ArticlePharmacoepidemiology and drug safety2022

Evolving channeling in prescribing SGLT-2 inhibitors as first-line treatment for type 2 diabetes.

HoJin Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.